Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03564886
Other study ID # 2011296
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 1, 2019
Est. completion date September 5, 2019

Study information

Verified date August 2020
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An isotonic solution, such as saline (0.9%, 300mOsm/L) or lactated ringer's (273 mOsm/L), is commonly used and safely proven for joint irrigation during arthroscopy. Arthroscopic fluid is usually pressurized to enable visualization through dilation of the joint or bursa and prevent bleeding from the microvasculature. It has been recommended that this pressure be maintained at 49mmHg or less below the systolic blood pressure to preserve the clarity of view. The combination of large amounts of pressurized irrigation solution and lengthy arthroscopic procedures may cause substantial tissue fluid retention. Thus, extravasation of irrigation fluid into the periarticular tissues is inevitable and may create technical difficulties as well as patient morbidity and complications. Previous investigators have reported complications including tracheal obstruction, post-operative airway edema and compromise leading to prolonged intubation, excess weight gain, neurologic injuries, skin necrosis, and fluid overload associated with excessive fluid extravasation and tissue retention. Furthermore, it has been shown that fluid accumulated during the operation is slowly released back into the systemic circulation. Although there is not a rapid change in circulating volume, there may be implications for elderly patients and those with multiple comorbidities during prolonged arthroscopic surgery. Therefore the investigators seek to determine if a hyperosmolar solution, similar to what is used in head trauma patients, can reduce the degree of fluid extravasation in knee arthroscopy. The investigators also seek to determine if a hyperosmolar solution has any effect on post-operative knee pain compared to the standard isotonic solution. The third objective is to determine if a hyperosmolar solution has any effect on post-operative pain medicine consumption compared to the standard isotonic solution.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date September 5, 2019
Est. primary completion date September 5, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients (18 years of age or greater) undergoing arthroscopic knee surgery who are willing and able to consent.

Exclusion Criteria:

- Current pregnancy or breastfeeding

- Unable to give consent

- Prisoner

- Mentally Disabled

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Hyperosmolar Saline
The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.
Normal saline
Lactate Ringer's (LR, 273mOsm/L)

Locations

Country Name City State
United States University of Missouri Health System Columbia Missouri

Sponsors (1)

Lead Sponsor Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fluid Extravasation To determine if a hyperosmolar solution, similar to what is used in head trauma patients, can change the degree of fluid extravasation in knee arthroscopy. Immediately Postoperatively
Secondary Postoperative Pain To determine if a hyperosmolar solution has any effect on post-operative knee pain (Visual Analogue Scale; 0-10; 0= no pain; 10= worst pain imaginable) compared to the standard isotonic solution. Post-operative Days 1, 2 and 3
Secondary Opioid Consumption To determine if a hyperosmolar solution has any effect on post-operative pain medicine consumption compared to the standard isotonic solution. Postoperative Days 1, 2 and 3.
See also
  Status Clinical Trial Phase
Completed NCT01650519 - A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery Phase 4
Completed NCT02001662 - Adductor Canal Block and Arthroscopic Knee Surgery, High Pain Responders Phase 4
Completed NCT04759742 - The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery Early Phase 1
Recruiting NCT06382896 - Effect of Oliceridine on Rebound Pain
Completed NCT02089932 - Dexmedetomidine in Different Dose Levels as Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block. Phase 4
Completed NCT01701102 - Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery N/A
Completed NCT04322760 - Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery N/A
Not yet recruiting NCT02742376 - Comparison of Gait Parameters Between Floor and Sponge Surfaces and Special Shoes N/A